The GVB Biopharma CBT Isolate has been announced by the hemp-derived product developer, manufacturer and global distributor as a versatile solution for elevating the cannabis wellness market. The cannabicitran solution features a potent amount of the rare cannabinoid, and thus offers distinct properties along with potential benefits. The solution has underwent in-house testing on a rigorous level to ensure the brand’s continued commitment to quality assurance, and is reported to be great for topicals, tinctures, edibles and more.

CEO Drew Spiegel spoke on the GVB Biopharma CBT Isolate saying, “Our introduction of CBT Isolate underscores our dedication to leading the industry in both quality and innovation. Rare cannabinoids are at the forefront of new product development, and GVB Biopharma strives to give our customers the best-in-class, high-purity ingredients they need to create differentiated and effective formulations.”

Image Credit: GVB Biopharma